Image 1-Zepzelca (lurbinectedin) - Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

Zepzelca (lurbinectedin) for the Treatment of Small Cell Lung Cancer

Image 1-Zepzelca (lurbinectedin)
Zepzelca is a prescription drug used to treat adult patients with metastatic small cell lung cancer (SCLC). Credit: Jazz Pharmaceuticals plc.